This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Viravaxx Gmbh. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Verena Niederberger-Leppin: Innovator in Rhinovirus Diagnosis
Introduction
Verena Niederberger-Leppin is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceutical compositions, particularly in diagnosing rhinovirus infections. Her innovative approach has the potential to enhance diagnostic methods and improve patient outcomes.
Latest Patents
Verena holds a patent for a method of diagnosing a rhinovirus infection. The patent describes a pharmaceutical composition that includes at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues. This composition comprises amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3, and VP4. This invention represents a significant advancement in the field of virology.
Career Highlights
Throughout her career, Verena has worked with various companies, including Viravaxx GmbH and Viravaxx AG. Her work in these organizations has allowed her to apply her expertise in developing innovative solutions for viral infections.
Collaborations
Verena has collaborated with esteemed colleagues such as Rudolf Valenta and Katarzyna Niespodziana. These partnerships have contributed to her research and development efforts in the field of rhinovirus diagnostics.
Conclusion
Verena Niederberger-Leppin is a pioneering inventor whose work in diagnosing rhinovirus infections showcases her commitment to advancing medical science. Her contributions are invaluable in the ongoing fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile